Publications by authors named "Annie Luetkemeyer"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

108,360

Total Likes

1,424

Extended Reach

1,456,499

Social Features

310
R
Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline

N Engl J Med· November 2020

Videos about Article: user user user 5

8 3 50 299 100 827 24

View All Article and Social Media Activity
F
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study.
Colleen A McGourty, Diana Ung, Mackenzie Clark, Jennifer Nguyen, Claire McDonell, Annie Luetkemeyer

Int J Drug Policy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial.
Meghan D Morris, Claire McDonell, Annie F Luetkemeyer, Robert Thawley, Jeff McKinney

JAMA Netw Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Annie Luetkemeyer

Open Forum Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
Angela Branche, Nadine Rouphael, David Diemert, Ann Falsey, Cecilia Losada, Annie Luetkemeyer

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.
Andrea B Troxel, Eva Petkova, Keith Goldfeld, Mengling Liu, Thaddeus Tarpey, Annie F Luetkemeyer

JAMA Netw Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.
Mark Sulkowski, Annie F Luetkemeyer, David L Wyles, Claudia Martorell, Andrew Muir

Aliment Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome.
Carlos A M Silva, Barbara Graham, Kristofor Webb, Laura Vari Ashton, Marisa Harton, Annie F Luetkemeyer

Int J Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
Susanna Naggie, Daniel S Fierer, Michael D Hughes, Arthur Y Kim, Annie Luetkemeyer

Clin Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized US Efforts to Eliminate Hepatitis C.
Annette Gaudino, Bryn Gay, Clifton Garmon, Mike Selick, Reed Vreeland, Annie Luetkemeyer

Infect Dis Clin North Am· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
David Wyles, Heiner Wedemeyer, Ziv Ben-Ari, Edward J Gane, Jesper Bach Hansen, Annie Luetkemeyer

Hepatology· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
Mark Nelson, Rafael Rubio, Adriano Lazzarin, Svetlana Romanova, Annie Luetkemeyer

J Interferon Cytokine Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.
Kristen M Marks, Douglas Kitch, Raymond T Chung, Colleen Hadigan, Janet Andersen, Annie Luetkemeyer

J Acquir Immune Defic Syndr· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
Payam Nahid, Jussi Saukkonen, William R Mac Kenzie, John L Johnson, Patrick P J Phillips, Annie Luetkemeyer

Am J Respir Crit Care Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis as part of the natural history of HIV infection in developing countries.
Gabriel Chamie, Annie Luetkemeyer, Edwin Charlebois, Diane V Havlir

Clin Infect Dis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.
Annie F Luetkemeyer, Edwin D Charlebois, Laura L Flores, David R Bangsberg, Steven G Deeks

Am J Respir Crit Care Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and TB.
Soumya Swaminathan, Annie Luetkemeyer, Padmini Srikantiah, Royce Lin, Edwin Charlebois

Trop Doct· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.
Annie Luetkemeyer, C Bradley Hare, John Stansell, Phyllis C Tien, Edwin Charlesbois

J Acquir Immune Defic Syndr· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis